-+ 0.00%
-+ 0.00%
-+ 0.00%

Aytu Biopharma publishes investor presentation on its CNS-focused prescription portfolio and EXXUA for major depressive disorder

Reuters·03/17/2026 21:09:40

Please log in to view news